In the last trading session, 2.65 million Oscar Health Inc (NYSE:OSCR) shares changed hands as the company’s beta touched 1.68. With the company’s per share price at $14.93 changed hands at $0.76 or 5.36% during last session, the market valuation stood at $3.69B. OSCR’s last price was a discount, traded about -59.34% off its 52-week high of $23.79. The share price had its 52-week low at $10.45, which suggests the last value was 30.01% up since then. When we look at Oscar Health Inc’s average trading volume, we note the 10-day average is 3.12 million shares, with the 3-month average coming to 4.25 million.
Analysts gave the Oscar Health Inc (OSCR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.38. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended OSCR as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Oscar Health Inc’s EPS for the current quarter is expected to be -0.56.
Oscar Health Inc (NYSE:OSCR) trade information
Instantly OSCR was in green as seen at the end of in last trading. With action 1.43%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 11.09%, with the 5-day performance at 1.43% in the green. However, in the 30-day time frame, Oscar Health Inc (NYSE:OSCR) is 3.97% up. Looking at the short shares, we see there were 19.07 million shares sold at short interest cover period of 4.59 days.
The consensus price target for the stock as assigned by Wall Street analysts is 28, meaning bulls need an upside of 46.68% from its current market value. According to analyst projections, OSCR’s forecast low is 28 with 28 as the target high. To hit the forecast high, the stock’s price needs a -87.54% plunge from its current level, while the stock would need to soar -87.54% for it to hit the projected low.
Oscar Health Inc (OSCR) estimates and forecasts
Data shows that the Oscar Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -6.69% over the past 6 months, a 99.18% in annual growth rate that is considerably higher than the industry average of 9.80%. Year-over-year growth is forecast to reach 57.84% up from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 2.47B. 4 analysts are of the opinion that Oscar Health Inc’s revenue for the current quarter will be 2.79B. The company’s revenue for the corresponding quarters a year ago was 1.43B and 2.14B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 72.68%. The estimates for the next quarter sales put growth at 30.31%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -2.85%. The 2025 estimates are for Oscar Health Inc earnings to increase by 106.62%.
OSCR Dividends
Oscar Health Inc is expected to release its next quarterly earnings report in February.
Oscar Health Inc (NYSE:OSCR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.08% of Oscar Health Inc shares while 88.61% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 91.42%. There are 88.61% institutions holding the Oscar Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.5114% of the shares, roughly 17.38 million OSCR shares worth $275.03 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.1246% or 14.18 million shares worth $224.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Smallcap World Fund . With 6.0 shares estimated at $89.51 million under it, the former controlled 2.83% of total outstanding shares. On the other hand, Smallcap World Fund held about 2.48% of the shares, roughly 5.25 shares worth around $78.34 million.